http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20210044242-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b057a188765c2d804244b117e5744a5a
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0605
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0657
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0608
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
filingDate 2019-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f9015ca6e9770c32fdf155acf7bc61f7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0bdcc90599be739549f685d72c5daa7c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f28a4887c043df0cefb84d25f7ed303a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fb2468ae8623b3166e7da649dac9e5fb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fa7e9b82c54c8e353a68bef7f76e82b0
publicationDate 2021-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-20210044242-A
titleOfInvention Drugs used to treat tissue necrosis and improve heart function
abstract The present invention refers to drugs used for tissue necrosis due to blood deficiency and oxygen deficiency, and the drugs include amniotic fluid or extracts thereof from non-human animals, especially poultry and non-human mammals, and mediators that can be accepted in a pharmacy arbitrarily selected. . The drug combination of the present invention promotes cell growth, enhances cardiac function after myocardial infarction, and promotes regeneration of heart cells after myocardial infarction.
priorityDate 2018-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450313723
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454007995
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135871623
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID28179
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24502
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409089499
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7058172
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559561
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419565814
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID74358
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO01945
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID977
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523291

Total number of triples: 40.